ATryn is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Revo Biologics, Inc.. The primary component is Antithrombin Alfa.
| Product ID | 42976-121_634fb454-4f7f-4b30-9f89-fd3a122cf074 | 
| NDC | 42976-121 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | ATryn | 
| Generic Name | Antithrombin Recombinant | 
| Dosage Form | Injection, Powder, Lyophilized, For Solution | 
| Route of Administration | INTRAVENOUS | 
| Marketing Start Date | 2009-05-06 | 
| Marketing Category | BLA / BLA | 
| Application Number | BLA125284 | 
| Labeler Name | rEVO Biologics, Inc. | 
| Substance Name | ANTITHROMBIN ALFA | 
| Active Ingredient Strength | 1750 [iU]/mL | 
| Pharm Classes | Decreased Coagulation Factor Activity [PE],Thrombin Inhibitors [MoA],Factor Xa Inhibitors [MoA],Recombinant Antithrombin [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2022-12-31 | 
| Marketing Start Date | 2009-05-06 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | BLA | 
| Application Number | BLA125284 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2009-05-06 | 
| Inactivation Date | 2020-01-31 | 
| Ingredient | Strength | 
|---|---|
| ANTITHROMBIN ALFA | 1750 [iU]/1 | 
| SPL SET ID: | ed3eaf69-1cbd-4b01-a6fa-1fe02c90c3e1 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 42976-121 | ATryn | Antithrombin Recombinant | 
| 42976-125 | ATryn | Antithrombin Recombinant | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  ATRYN  76184729  2743233 Live/Registered | REVO BIOLOGICS, INC. 2000-12-20 |